Here's a Multibillion-Dollar Market for Johnson & Johnson
In this video from Motley Fool Live, recorded on March 22, Fool.com contributors Brian Orelli and Keith Speights discuss the prospects for Ponvory, which may be narrow because of its late entry into the space. Brian Orelli: Johnson & Johnson gained FDA approval for Ponvory.